Period Ending | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 | Mar 30, 2012 |
---|
Total Revenue
|
1,821,000
|
1,734,000
|
1,828,000
|
1,866,000
| Cost of Revenue | 582,000 | 558,000 | 578,000 | 631,000 | |
Gross Profit
|
1,239,000
|
1,176,000
|
1,250,000
|
1,235,000
| |
|
Operating Expenses |
|
Research Development | 238,000 | 220,000 | 213,000 | 215,000 |
|
Selling General and Administrative | 643,000 | 569,000 | 648,000 | 669,000 |
|
Non Recurring | 144,000 | 894,000 | 3,877,000 | 58,000 |
|
Others | 101,000 | 99,000 | 98,000 | 97,000 |
|
|
|
Total Operating Expenses | 1,126,000 | 1,782,000 | 4,836,000 | 1,039,000 | | |
Operating Income or Loss
|
117,000
|
(595,000)
|
(3,586,000)
|
196,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 3,000 | 7,000 | 31,000 | (4,000) |
|
Earnings Before Interest And Taxes | 116,000 | (599,000) | (3,555,000) | 192,000 |
|
Interest Expense | 64,000 | 65,000 | 63,000 | 69,000 |
|
Income Before Tax | 52,000 | (664,000) | (3,618,000) | 123,000 |
|
Income Tax Expense | (9,000) |
-
| (40,000) | 10,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 61,000 | (664,000) | (3,578,000) | 113,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
61,000
|
(664,000)
|
(3,578,000)
|
113,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
61,000
|
(664,000)
|
(3,578,000)
|
113,000
|
|